New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
07:09 EDTGSK, MYLMylan wins restraining order against Apotex for generic version of GSK's Paxil
Mylan (MYL) announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex Inc. and Apotex Corporation in litigation relating to Paroxetine CR, the authorized generic of GlaxoSmithKline's (GSK) Paxil CR. The District Court ordered Apotex to immediately discontinue all sales and supply of Paroxetine CR. Mylan previously obtained an order enjoining GlaxoSmithKline from supplying Paroxetine CR to Apotex. Mylan has an exclusive license to an Orange Book patent pertaining to Paxil CR which expires in July 2016.
News For MYL;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 8, 2015
16:22 EDTMYLOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTMYLActionable Options for Wednesday, April, 8
Subscribe for More Information
15:27 EDTMYLMylan hasn't made compelling case for Perrigo adding value, says BMO Capital
Subscribe for More Information
15:16 EDTMYLPerrigo not likely interested in a Mylan deal, says BMO Capital
14:23 EDTMYLAdditional bidders for Perrigo could emerge after Mylan offer, says Stifel
Subscribe for More Information
13:07 EDTMYLMylan bid for Perrigo makes strategic sense, says JPMorgan
Subscribe for More Information
13:03 EDTMYLPerrigo says board will meet to discuss Mylan proposal
Subscribe for More Information
12:17 EDTMYLOn The Fly: Midday Wrap
Subscribe for More Information
11:51 EDTMYLPerrigo calls active on Mylan proposal to acquire for $205 per share
Subscribe for More Information
11:45 EDTMYLMylan volatility up after proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:40 EDTMYLPerrigo up $47.10 to $211.81, trading above Mylan's $205/share proposal
Subscribe for More Information
11:35 EDTMYLGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
Subscribe for More Information
11:34 EDTMYLGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
11:32 EDTMYLMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:31 EDTMYLPerrigo halted for volatility after jumping 7% to $176.42
Subscribe for More Information
11:29 EDTMYLMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
07:16 EDTMYLMylan one of the cheapest names in Specialty Pharma, says JPMorgan
Subscribe for More Information
April 7, 2015
10:19 EDTMYLHigh option volume stocks
Subscribe for More Information
07:32 EDTMYLMylan launches Norethindrone and Ethinyl Estradiol Tablets in U.S.
Subscribe for More Information
07:14 EDTGSKEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use